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Abstract: 15 
The CT appearance of canine adrenal masses has been reported, but associations 16 
between imaging features and pathologic features of these lesions have not been 17 
investigated in detail. In order to test the associations between different types of adrenal 18 
neoplasia and their CT and pathologic features, a retrospective study was performed. 19 
Seventeen dogs that had histologic diagnosis of primary adrenal neoplasia following a CT 20 
contrast of the abdomen and surgical resection of the mass or necropsy examination were 21 
included in the study. CT images and histopathologic specimens were reviewed 22 
independently by two radiologists and a pathologist, respectively. Diagnoses were 23 
adenocarcinoma in 9 (53%) dogs, pheochromocytoma in 5 (29%) dogs, and adenoma in 24 
3 (18%) dogs. Pheochromocytoma was associated with CT signs of vascular invasion 25 
(likelihood ratio=4.8, 95% CI=1.3-18.3, P=0.03) and macroscopic vascular invasion 26 
(likelihood ratio=9.6, 95% CI=1.4-65.9, P=0.02). There was excellent agreement between 27 
signs of vascular invasion in CT images and vascular invasion at surgery or necropsy 28 
(kappa=0.86, P=0.001). A peripheral contrast-enhancing rim in delayed post-contrast CT 29 
images was associated with fibrous encapsulation of the tumor (kappa=0.53, P=0.05), 30 
and a heterogeneous pattern of contrast distribution in delayed post-contrast CT images 31 
was associated with adrenal hemorrhage or infarction on histological examination 32 
(kappa=0.45, P=0.05). Although CT enabled assessment of features that reflect their 33 
biological behavior of adrenal neoplasms with good agreement with pathological 34 
findings, the overlap in pathologic features between tumor types will limit the potential 35 
for those tumor types to be distinguished by CT.   36 
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Introduction: 37 
Primary adrenal neoplasia is an uncommon, but well recognized condition in dogs1. 38 
Adrenal adenoma, adenocarcinoma and pheochromocytoma are considered the most 39 
common tumors affecting the canine adrenal gland1,2,3,4. Adrenal myelolipoma, a benign 40 
tumor composed of adipose tissue and hematopoietic cells, has also been reported in 41 
dogs5,6. Adrenal neoplasms may cause a range of clinical signs, depending primarily on 42 
their endocrinological activity. Adrenocortical neoplasms producing cortisol cause signs 43 
of canine Cushing’s syndrome, including polyuria/polydipsia, polyphagia, hair loss, 44 
hepatomegaly and pendulous abdomen. Epinephrine or norepinephrine-secreting 45 
pheochromocytomas are associated with signs such as weakness, collapse, cardiac 46 
dysrhythmia or hypertension.  Endocrinologically inactive adrenal neoplasms usually 47 
cause non-specific clinical signs, including weight loss. Adrenal gland masses, both 48 
neoplastic and hyperplastic, are recognized frequently during abdominal imaging in 49 
older dogs, and in many instances are thought to be clinically silent ‘incidentalomas’4.  50 
Imaging of suspected adrenal neoplasia in dogs is performed with the intention of 51 
determining the anatomical origin of the tumor, its morphologic features, which may 52 
reflect biological behavior, and to look for signs of metastasis. Of the various adrenal 53 
neoplasms, malignant pheochromocytomas are considered the most aggressive, with 54 
direct invasion of adjacent vasculature reported in up to 85% dogs and distant metastasis 55 
in up to 40% dogs1,7,8.  56 
In humans computed tomography (CT) plays an important role in characterizing adrenal 57 
neoplasms9,10. The majority of adrenal adenomas and myelolipomas in humans contain a 58 
significant amount of intracellular fat, hence these benign tumors usually have lower x-59 
ray attenuation than malignant adrenal neoplasms9 and the combination of low density 60 
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values (<10 HU) in non-enhanced CT images and early contrast wash-in/wash-out 61 
through the mass seen in benign tumors, enables correct classification of benign versus 62 
malignant adrenal lesions in up to 96% of affected humans11. CT also enables detection 63 
of tumor- or blood clot-thrombus in vessels adjacent to the adrenal glands, which occurs 64 
as a result of invasion by malignant neoplasms12.  65 
CT has also been found to be a useful method for imaging the adrenal glands in dogs. The 66 
CT appearance of adrenal glands has been described in healthy dogs13,14, dogs with 67 
pituitary-dependent hyperadrenocorticism15,16,17, and dogs with primary adrenal 68 
neoplasia5,18,19,20. As in humans, CT is an accurate method for detection of vascular 69 
invasion by malignant adrenal neoplasms, with 92% sensitivity and 100% specificity in 70 
one study19. The histologic composition of adrenal neoplasms is somewhat 71 
heterogeneous in both humans and dogs with variable amounts of hemorrhage, necrosis 72 
and/or mineralization occurring in benign and malignant neoplasms10, 21, 22. As a result, 73 
different tumor types may appear similar in CT images5,19; however, previous studies of 74 
the CT appearance of canine adrenal tumors have not investigated in detail their imaging-75 
pathologic correlations.  76 
The aims of the present study were to: (1) test the associations between different types 77 
of adrenal neoplasia and histopathologic and CT imaging features (2) assess the 78 
agreement between CT imaging findings and analogous histopathologic features of 79 
adrenal neoplasms. 80 
 81 
Methods: 82 
Patient selection- The electronic patient record system at the Queen Mother Hospital 83 
for Animals (QMHA) was searched using the terms adrenalectomy, adrenal mass, 84 
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computed tomography, and dog. Pathological data for patients retrieved by this search 85 
was then sought in the QMHA’s clinical pathology database. Dogs that had abdominal CT, 86 
surgical resection of an adrenal mass or necropsy, and histological diagnosis of adrenal 87 
neoplasia were included in this study. The breed, age and gender of these dogs were 88 
recorded.  89 
CT imaging- All CT exams were performed using the same 16-slice scanner (Mx8000 IDT, 90 
Philips, Best, The Netherlands) with dogs in sternal recumbency under general 91 
anesthesia or sedation. All CT studies included one pre-contrast acquisition and at least 92 
one post-contrast acquisition of the abdomen. Non-ionic iodinated contrast medium, 93 
Iohexol (Omnipaque 350 mg/mL, Nycomed, Oslo) was administered as a bolus injection 94 
at a dose of 2 mL/kg using, when available, a pressure injector (Stellant, Medrad, 95 
Indianola, PA.) at a rate of 2 mL/s. Post contrast scans were obtained at 30s (early phase) 96 
or at 120s (delayed phase) after the start of contrast injection. When contrast was 97 
administered by hand injection, a first scan was typically acquired within 60s of the start 98 
of injection, followed by another scan at 120s. CT machine settings for image acquisition 99 
varied depending on the size of the patient. Typical settings were: helical mode, 2-3 mm 100 
slice thickness, 1 s rotation time, 1.25 pitch, 90 or 120 kVp, 100-150 mA, 500 mm 101 
acquisition field of view, standard reconstruction algorithm and 512x512 matrix.  102 
Two board-certified radiologists (LB, PM) unaware of the surgical and pathological 103 
results reviewed the images from the CT studies together and reached a consensus. CT 104 
images were displayed in an abdominal window (window level= 40 HU, window width= 105 
400 HU) on a workstation using commercially available DICOM image viewing software 106 
(OsiriX 64-bit, version 5.2.2, Pixmeo, Switzerland). CT images were reviewed with 107 
respect to a set of pre-considered criteria as follows: maximum diameter (mm) of the 108 
6 
 
mass in any reformatted plane (transverse, sagittal or dorsal); adrenal mass outline (well 109 
demarcated VS irregularly demarcated); shape (rounded VS lobulated); pattern of pre-110 
contrast attenuation (homogeneous VS heterogeneous); pattern of post-contrast 111 
enhancement (homogeneous VS heterogeneous) on early and delayed phases; presence 112 
of contrast enhancing peripheral rim on early and delayed phases; and irregular vessel 113 
lumen or intraluminal thrombus compatible with tumor invasion or blood clot within the 114 
ipsilateral phrenico-abdominal vein, renal vein or caudal vena cava. Average attenuation 115 
and standard deviation (SD) in Hounsfield Units (HU) of each adrenal mass was measured 116 
on pre-contrast, early- and delayed-phase post-contrast images by manually drawing a 117 
region of interest to fit the mass in each image in each plane in which the mass appeared 118 
largest. Attenuation data were regrouped into categories of contrast enhancement: slight 119 
(< 60HU), moderate (≥60, <110) and marked (≥110).  120 
Pathology– The method of examining each adrenal mass (i.e. surgical adrenalectomy VS 121 
necropsy), laterality of the adrenal mass and the presence or absence of macroscopic 122 
vascular invasion were recorded. A board-certified pathologist (SP) reviewed archived 123 
histopathology samples from the adrenal lesions, being unaware of imaging findings. 124 
Variables evaluated based on review of ten x400 high power fields were: mitotic index,  125 
cellular differentiation (well-differentiated; moderately well-differentiated; poorly 126 
differentiated), percentage of necrosis (N0<10%; N1= 10%-25%; N2= 26%-50%; N3= 127 
>50%), presence of hemorrhage or infarction, presence of peripheral capsular invasion, 128 
microscopic vascularity (slight, moderate, marked) and presence of microscopic vascular 129 
invasion. Classification of tumor grade (high or low) was based on these results: tumor 130 
was considered of high grade if for 3 or more results were positive or classified in the 131 
higher category group. The pathologist formulated a final diagnosis (i.e. adrenocortical 132 
adenoma, adrenocortical adenocarcinoma or pheochromocytoma) for each adrenal mass. 133 
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Because low-grade adrenocortical adenocarcinomas and adenomas are often difficult to 134 
differentiate 7, the classification of benign VS malignant was based on combined criteria 135 
including mitotic index, tumor grade, capsular invasion and presence of microscopic 136 
vascular invasion.  137 
Statistical analysis- Statistical calculations were performed using commercially 138 
available software (SPSS® Software, Version 20.0.0, IBM Corp, Armony, NY). Fisher’s 139 
exact test was used to test the association between diagnosis (i.e. adrenocortical 140 
adenoma, adrenocortical adenocarcinoma or pheochromocytoma) and each of the 141 
following categorical variables: breed, gender, mitotic index, cellular differentiation, 142 
percentage of necrosis, presence of areas of hemorrhage or infarction, presence of 143 
peripheral capsular invasion, microscopic vascularity, presence of microscopic vascular 144 
invasion, macroscopic vascular invasion, tumor grade, outline, shape, pattern of pre-145 
contrast attenuation, pattern of post-contrast enhancement on early and delayed phases, 146 
presence of contrast enhancing peripheral rim on early and delayed phases, presence of 147 
tumor invasion within the adjacent vasculature and degree of contrast enhancement on 148 
early and delayed phases. Monte Carlo estimation for Fisher’s exact test was used when 149 
a count less than 5 elements per cell was expected in a variable including more than two 150 
categories. Likelihood ratios (and 95% confidence intervals, CI) were calculated for 151 
results with P<0.05. Continuous data (e.g. age, maximum diameter of the mass on CT, 152 
average HU on pre-contrast, early and delayed phases, difference of average HU between 153 
early or delayed post-contrast and pre-contrast phases) was tested for normality using 154 
the Shapiro-Wilk test, and relationships between these variables and diagnosis were 155 
tested using analysis of variance.  For all statistical tests, results with P<0.05 were 156 
considered to be significant. 157 
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Certain CT features and pathological features were considered analogous. Agreement 158 
between the following binomial CT and histopathology features was tested using the 159 
kappa statistic: presence of areas of hemorrhage or infarction VS pattern of contrast 160 
enhancement on early and delayed phases, presence of peripheral capsular invasion VS 161 
mass outline, presence of peripheral capsular invasion VS contrast enhancing rim on 162 
early and delayed phase, presence of macroscopic vascular invasion VS presence of 163 
vascular invasion on CT post contrast images. Rank correlation between the following 164 
ordinal CT and histopathology features was tested using Kendall’s Tau b or c tests: 165 
percentage of necrosis VS pattern of contrast enhancement on early and delayed phases, 166 
microscopic vascularity VS degree of contrast enhancement on early and delayed phase.  167 
Statistical tests were performed by two authors (TG, CRL). 168 
 169 
Results: 170 
Seventeen dogs with a total of 17 adrenal masses were included in this study. Tumors 171 
were diagnosed as adrenocortical adenocarcinoma (n=9, 53%), pheochromocytoma 172 
(n=5, 29%), and adrenocortical adenoma (n=3, 18%). These masses were analyzed either 173 
after they were removed by surgical adrenalectomy (n=15, 88%) or on post-mortem 174 
examination (n=2, 12%). More tumors affected the left adrenal gland (n=11, 65%) than 175 
the right (n=6, 35%). Median age of the patients was 10 years (range: 5-15 years). Breeds 176 
were German shepherd (n=2), Golden retriever (n=2) and Lurcher (n=2), Boxer (n=1), 177 
Cocker Spaniel (n=1), Collie (n=1), Fox Terrier (n=1), Jack Russell Terrier (n=1), Labrador 178 
(n=1), Miniature Poodle (n=1), Rottweiler (n=1), Shih Tzu (n=1), West Highland White 179 
terrier (n=1) and cross breed (n=1). 180 
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Relationships between tumor type and pathological findings are summarized in Table 1. 181 
The only significant association found was between pheochromocytoma and presence of 182 
macroscopic vascular invasion (likelihood ratio=9.6, 95% CI 1.4-65.9).  183 
Relationships between tumor type and CT features are summarized in Table 2. In three 184 
dogs, only the early post-contrast CT images were available for review. There was a 185 
significant association between pheochromocytoma and CT signs of vascular invasion or 186 
thrombus formation (likelihood ratio=4.8, 95% CI 1.3-18.3). The higher mean HU pre-187 
contrast for pheochromocytoma compared to other neoplasms was of borderline 188 
significance (P=0.06). No other significant associations were found.  189 
Results of the agreement or correlation between analogous histopathological and CT 190 
findings are summarized in Table 3. There was moderate agreement between absence of 191 
peripheral capsular invasion by neoplastic cells on histopathology and the presence of an 192 
enhancing rim on post-contrast late phase CT images (kappa=0.53, P=0.05). There was 193 
excellent agreement with respect to presence of vascular invasion (kappa=0.86, 194 
P=0.001).  In one dog the adrenal mass was considered to be invasive because of marked 195 
impingement on the caudal vena cava and focal irregularity in intraluminal contrast 196 
observed in CT images; however, no evidence of vascular invasion by this mass was 197 
identified during surgery or on histopathologic examination. There was moderate 198 
agreement between hemorrhage or infarction seen histologically and a heterogeneous 199 
pattern of post contrast enhancement in late phase CT images (kappa=0.45, P=0.05).  200 
 201 
Discussion: 202 
CT is now routinely used in referral practices for the preoperative assessment of dogs 203 
with an adrenal mass because it is considered more accurate than abdominal 204 
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ultrasonography for the detection of the vascular invasion19. In the present study there 205 
was excellent agreement between signs of vascular invasion in CT images and finding 206 
vascular invasion at surgery or necropsy. A discrepancy (false positive) was identified in 207 
only one dog; hence sensitivity, specificity and accuracy of CT for vascular invasion in this 208 
study were respectively 92%, 89% and 94%. The single erroneous CT interpretation of 209 
vascular invasion probably occurred because of the marked compression of the caudal 210 
vena cava by the adrenal mass, which caused narrowing of the vessel lumen. Such 211 
impingement may alter the blood flow and disrupt the pattern of post-contrast 212 
enhancement of these vessels, mimicking a thrombus, which is the principal imaging sign 213 
of vascular invasion. The presence of vascular invasion influences the choice of surgical 214 
approach for tumor resection24, although there appear to be no significant differences in 215 
perioperative morbidity and mortality rates between patients with or without a tumor-216 
associated thrombus.  217 
Pheochromocytoma appears more likely to invade adjacent vessels than adrenocortical 218 
adenoma or adenocarcinoma (Fig. 1), as has been reported previously25; however, this 219 
finding at surgery or necropsy result was not associated with microscopic vascularity or 220 
histological signs of vascular invasion within this tumor. In two dogs, one with a high-221 
grade pheochromocytoma and one with a high-grade adenocarcinoma, there was 222 
evidence of peripheral capsular invasion by the tumor, with additional focal infiltration 223 
of neoplastic cells in the adipose tissue surrounding the gland in the dog with 224 
pheochromocytoma. Pheochromocytoma invading the hypaxial and epaxial musculature 225 
has been reported in dogs18,19, but this feature was not observed in dogs in the present 226 
study.  227 
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The presence of a peripheral contrast-enhancing rim in late phase CT images was 228 
associated with fibrous encapsulation of the tumor on histological examination (Fig. 2). 229 
A fibrous pseudocapsule (composed of compressed adjacent soft tissues), free of 230 
neoplastic cell infiltration is recognized more frequently in well-differentiated and low-231 
grade tumors. All adrenal adenomas in the present study had both CT and 232 
histopathological features compatible with a pseudo-capsule around the tumor. Finding 233 
a peripheral contrast-enhancing rim and absence of signs of vascular invasion in CT 234 
images of an adrenal mass suggests benign behavior. In contrast, the capsular infiltration 235 
identified in two dogs with high-grade adenocarcinoma and pheochromocytoma, 236 
respectively, was indicative of the malignant biological behavior of these tumors.  237 
Necrosis and hemorrhage are common in adrenal tumors18,23, and these features were 238 
considered responsible for the variable echogenicity of adrenal tumors in one study21. 239 
Similarly, in the present study, the presence of hemorrhage or infarction within an 240 
adrenal mass was associated with a heterogeneous pattern of contrast enhancement on 241 
late phase CT images (Fig.3). Masses with a homogeneous post contrast enhancement 242 
were less likely to contain foci of hemorrhage or infarction. In a report of four dogs with 243 
pheochromocytoma, the adrenal masses also had variable appearance in CT images, with 244 
multiple foci of low attenuation interspersed with hyperattenuating, highly vascularized 245 
areas18. It may not be possible to distinguish types of adrenal tumor based on CT features 246 
such as pre-contrast pattern of attenuation or degree or pattern of post-contrast 247 
enhancement because hemorrhage or necrosis are liable to occur when any tumor 248 
reaches a certain size.  249 
In humans, adrenal adenomas may be recognized by CT because of their characteristic 250 
low x-ray attenuation that occurs due to the presence of fat-laden cells in up to 70% of 251 
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these tumors9,26. Intracellular lipid-rich substances such as cholesterol and fatty acids 252 
have also been reported in canine patients with adrenal hyperplasia and adenomas2. A 253 
report of CT findings in a dog with bilateral adrenal adenomas and myelolipomas 254 
described one enlarged gland with a hypoattenuating center (-56HU) compatible with fat, 255 
while the contralateral adrenal gland was more homogeneous with a higher attenuation 256 
(39HU)5. The latter value is similar to the mean HU value (40.8HU) found for adenomas 257 
in pre-contrast CT images in the present study. These values are also similar to the HU 258 
values of 31.8 and 33.1 reported for hyperplastic adrenal glands in dogs with pituitary 259 
microadenoma or macroadenoma15. A recent study found that pheochromocytomas had 260 
higher mean attenuation (44.5HU) than adrenal adenocarcinomas (28.2HU)27. 261 
Interestingly, we also found evidence that the mean pre-contrast HU value for 262 
pheochromocytomas may be higher than for other adrenal neoplasms, although this 263 
result was of borderline significance.  264 
Another criterion used in humans to differentiate adrenal adenomas from malignant 265 
tumors is the early contrast wash-out associated with adenomas that is observed in 266 
delayed (typically at 15 minutes) post-contrast images11,28. We found no significant 267 
differences in the degree of enhancement or HU values measured in post-contrast CT 268 
images of different tumor types. Similarly no significant differences were found in their 269 
microscopic vascularization. These results differ from results presented in two recent 270 
studies in which pheochromocytoma was found to have more marked contrast 271 
enhancement than adenocarcinoma27,29; however, it is uncertain if this difference in 272 
results occurred because of differences in the timing of post-contrast acquisitions as this 273 
information was not included.  274 
13 
 
The present study has several limitations. The relatively small number of adrenal tumors 275 
included limits the power of the statistical tests. Inclusion criteria (e.g. final histologic 276 
diagnosis after adrenalectomy or post mortem examination) may have caused a patient 277 
selection bias in favor of dogs with more marked clinical signs and more 278 
endocrinologically active or malignant tumors, such as some adenocarcinomas and 279 
malignant pheochromocytomas, at the expense of dogs with adenomas7,25. There are also 280 
limitations in the comparison of CT and pathological findings. Histologic sections reveal 281 
microscopic structures below the resolution of CT scanners, and usually cover only a 282 
small part of a lesion observed by CT, hence discrepancies in the presence and extent of 283 
reported abnormalities are inevitable.  The retrospective nature of the study limited the 284 
amount of information available, particularly about other macroscopic pathologic 285 
features, which may have helped distinguish tumor types of strengthened imaging-286 
pathological correlations.  287 
Another possible limitation might be the method used to evaluate the microscopic 288 
vascularity of adrenal tumors, which was based on partially subjective criteria 289 
(pathologist’s judgment, based on review of ten x400 high power fields for each slide). 290 
Quantitative methods of assessment of tumoral microvasculature (e.g. microscopic 291 
vascular density) have been reported as a method to evaluate the response of a tumor to 292 
antiangiogenic therapy.30 It is unclear if this method offers advantages over the subjective 293 
method used because it is also susceptible to variability because of  heterogeneity within 294 
a mass.  295 
In conclusion, although CT enabled assessment of features that reflect the biological 296 
behavior of adrenal neoplasms with good agreement with pathological findings, the 297 
overlap in pathologic features between tumor types will limit the potential for those 298 
14 
 
tumor types to be distinguished by CT. Further studies of a larger number of dogs are 299 
needed to support our results.   300 
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Table 1. Relationships between tumor type and histopathological findings 
 Adenoma 
n=3 
Adenocarcinoma 
n=9 
Pheochromocytoma 
n=5 
P-value 
 
Mitotic index  MI0=2, MI2=1 MI0=3, MI1=1, MI2=4, MI4=1 MI0=2, MI1=2, MI3=1,  0.48 
Cellular differentiation Well differentiated=3 Well differentiated=4  
Moderately differentiated=3  
Poorly differentiated=2 
Well differentiated=4  
Moderately differentiated=1  
0.38 
% of necrosis  N0=3 N0=6; N1=1; N2=1; N3=1 N0=3; N1=2 0.81 
Hemorrhage/infarction No=2;Yes=1 No=7;Yes=2 No=2;Yes=3 0.54 
Capsular invasion No=3 No=6;Yes=3 No=4;Yes=1 0.66 
Microscopic vascularity Mild=2;Moderate=1 Mild=4;Moderate=2;Marked=3 Mild=1;Moderate=1;Marked=3 0.61 
Microscopic vascular 
invasion 
No=2;Yes=1 No=5;Yes=4 No=1;Yes=4 0.43 
Macroscopic vascular 
invasion 
No=3 No=8;Yes=1 No=1;Yes=4 0.02  
Tumor grade Low=3 Low=4;High=5 Low=1;High=4 0.1 
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Table 2. Relationships between tumor type and CT features 
 Adenoma 
n=3 
Adenocarcinoma 
n=9 
Pheochromocytoma 
n=5 
P-value 
 
Maximum diameter (mm) Mean= 25.3 +/- 4.6 SD Mean= 29.5 +/- 14.1 SD Mean= 41.4 +/- 18.4 SD 0.26 
Outline Irregular demarcation=1 
Well demarcated=2 
Irregular demarcation =1 
Well demarcated=8 
Irregular demarcation =2 
Well demarcated=3 
0.77 
Shape Rounded=3 Rounded=8;Lobulated=1 Rounded=2;Lobulated=3 0.12 
Pattern pre-contrast attenuation  Heterogeneous=2;Homogeneous=1 Heterogeneous=4;Homogeneous=5 Heterogeneous=4;Homogeneous=1 0.54 
Pattern post-contrast 
enhancement (early) 
Heterogeneous=3 Heterogeneous=3;Homogeneous=6 Heterogeneous=4;Homogeneous=1 0.14 
Pattern post-contrast 
enhancement (late) 
Heterogeneous=2;Homogeneous=1 Heterogeneous=1;Homogeneous=6 Heterogeneous=3;Homogeneous=1 0.22 
Contrast-enhancing rim (early) Yes=3 No=6;Yes=3 No=3;Yes=2 0.17 
Contrast-enhancing rim (late) Yes=3 No=5;Yes=2 No=3;Yes=1 0.12 
Vascular invasion No=2;Yes=1 No=8;Yes=1 No=1;Yes=4 0.03 
Mean HU pre-contrast Mean= 40.8 +/- 14.3 SD Mean= 36.7 +/- 11.8 SD Mean= 52.3 +/- 5 SD 0.06 
Mean HU post-contrast (early) Mean= 66.7+/- 8.3 SD Mean= 83.9+/- 52.7 SD Mean= 103 +/- 21.7 SD 0.49 
Mean HU post-contrast (late) Mean= 55.5 +/- 22.4 SD Mean= 76.9 +/- 28.4 SD Mean= 93.4 +/- 14.3 SD 0.16 
Degree of contrast enhancement 
(early) 
Mild=1;Moderate=2 Mild=5;Moderate=3; Marked=1 Moderate=4; Marked=1 0.227 
Degree of contrast enhancement 
(late) 
Moderate=3 Mild=4;Moderate=3 Moderate=3; Marked=1 0.09 
HU difference pre-post (early) Mean= 25.9 +/- 21.3 SD Mean= 47.2 +/- 46.5 SD Mean= 50.6 +/- 23.6 SD 0.65 
HU difference pre-post (late) Mean= 14.7 +/- 21.7 SD Mean= 41.8+/-17.7 SD Mean= 42.8 +/- 14.2 SD 0.09 
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Table 3. Agreement or correlation between analogous histopathological and CT features 
Histopathological feature CT feature Statistic P-value 
Capsular invasion  Outline 0.3 a 0.5 
Capsular invasion Contrast-enhancing rim (early) 0.27 a 0.29 
Capsular invasion Contrast-enhancing rim (late) 0.53 a 0.05 
Vascular invasion Vascular invasion 0.86 a 0.001 
% necrosis  Post-contrast enhancement (early) 0.069 b  0.77 
% necrosis  Post-contrast enhancement (late) -0.02 b  1 
Hemorrhage or infarction  Pattern of post-contrast enhancement (early) 0.37 a  0.3 
Hemorrhage or infarction  Pattern of post-contrast enhancement (late) 0.45 a  0.05 
Microscopic vascularity  Degree of contrast enhancement (early) -0.03 b 0.91 
Microscopic vascularity  Degree of contrast enhancement (late) -0.36 b 0.18 
 
a Kappa; b Kendall’s tau
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Legends: 
 
  
A   B  
Fig. 1.   A) Transverse and B) sagittal post-contrast CT images showing vascular invasion 
of a left adrenal mass. There is a contrast enhancing mass (*) within the lumen of the 
caudal vena cava (CVC). 
 
A  B  
Fig. 2.   A) Transverse post-contrast CT image showing thin, peripheral rim of 
enhancement (arrowheads) in a left adrenal mass. B) Corresponding histologic section 
showing a layer of fibrous tissue (arrowheads) forming a pseudo-capsule around the 
tumor (T). 
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A   
B  
Fig. 3.    A) Transverse pre- (left) and post-contrast (right) CT images of a large left 
adrenal mass. The lesion has faintly heterogeneous attenuation in the pre-contrast image. 
Several non-contrast enhancing areas representing hemorrhage (H) within the tumor 
become apparent after contrast administration. B) Corresponding histologic section of 
the same mass showing irregular areas of hemorrhage (H) within the tumor (T). 
